Berkeley Lights, Inc. (NASDAQ:BLI)âs Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 57.75% of Berkeley Lights, Inc. shares, and 27.43% of them are in the hands of institutional investors. This is a new way to capture and interpret the qualitative language of biology and translate it into single-cell specific digital information, referred to as Digital Cell Biology. Get in Touch with Berkeley ⦠Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info; This information is available in the PitchBook Platform. Berkeley Lights Reports Fourth Quarter and Full Year 2020 Results and Provides Outlook for Full Year 2021. The Berkeley Lights IPO will trade on the Nasdaq under the ticker BLI. IBD Subscribers also enjoy ongoing investor training and support. GET QUOTE $ 67.83. Investors; Careers; Resources; Support; Get In Touch; Platform Rapid functional characterization of single cells. Request a free trial. Berkeley Lights has a market capitalization of US$5.4b, so it's too big to fly under the radar. 02.25.21 . Recent Highlights Increased revenue 31% for the fourth quarter and 13% for the full year 2020 ⦠But the many merits make a stake in this company attractive for risk-tolerant investors. Data Provided by Refinitiv. And as of September 29, 2020, it was holding 12.5% of the companyâs ⦠The ⦠Taking a look at our data on the ownership groups (below), it seems that institutional investors ⦠The expected return on investment is significant (above 40%). Categories. Nearly 57.75% of Berkeley Lights, Inc.âs shares belong to company insiders and institutional investors own 27.43% of the companyâs shares, according to Thomson Reutersâ data. Varian and Paxion Capital Partners are the most recent investors. You could use your skills to help our customers create revolutionary treatments for human disease. Four analysts have made estimates for Berkeley Lightsâ earnings, with the highest sales estimate coming in at $19.66 million and the lowest estimate coming in at $17.60 million. Berkeley acquires land differently to others. Investors are also buoyed by the number of investors in a company, with Berkeley Lights, Inc. having a total of 109 institutions that hold shares in the company. WHY BERKELEY LIGHTS Be a full time difference maker. Minimum 15 minutes delayed. Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. ASTâs telephone number is (718) 921-8300 or (800) 937-5449. The current price is about 17.94% off the estimated low and 54.8% off the forecast high, ⦠85. 4. Catch up on what you may have missed and get an inside look at Berkeley Lights. Investors are also buoyed by the number of investors in a company, with Berkeley Lights, Inc. having a total of 109 institutions that hold shares in the company. SC US (TTGP) Ltd is the top institutional holder at BLI for having 8.05 Million shares of worth $614.55 Million. Berkeley Lights, Inc. (BLI) estimates and forecasts. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and ⦠Get the latest Berkeley Lights, Inc. (BLI) stock news and headlines to help you in your trading and investing decisions. with >99% monoclonality assurance in just days. Berkeley Lights has a market capitalization of US$5.4b, so it's too big to fly under the radar. However, if you would like to, you can change your cookie settings at any time. Equities research analysts predict that Berkeley Lights, Inc. (NASDAQ:BLI) will report sales of $18.82 million for the current quarter, according to Zacks. BLI. Twitter. Berkeley's strategy has been developed for a cyclical market. BLI has shown strong financial results, operates on prospective and fast-growing market and has received support from famous investors. With a market cap near $6 billion, a high valuation and a relatively recent IPO Berkeley Lights isnât without risk; indeed, the stock is a more aggressive pick for the coming year. The stock currently has a share float of 64.91%. GROUP ⦠Berkeley Lights, Inc. is a Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in ⦠The lead underwriters are JPMorgan and Morgan Stanley. Berkeley Lights, Inc. (NASDAQ:BLI)âs Major holders. Berkeley Lights (BLI) in Focus: Stock Moves 6.3% Higher Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. The consensus among Wall Street research analysts is that investors should "buy" Berkeley Lights stock. Subscribe to Cabot Early Opportunities here⦠Courses on ⦠Berkeley Lights Inc. (NASDAQ:BLI) operates as a biotechnology company. Berkeley Lights went public in July following a wildly successful IPO that raised $205M â more than double the companyâs $100M filing. EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be ⦠View analyst ratings for Berkeley Lights or view top-rated stocks. Our goal is to establish the Berkeley Lights Platform as the standard throughout the cell-based product value chain by increasing the probability of successful product development for our customers. But IPOs aren't for everyone. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. Looking at the companyâs year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. Berkeley Lights expects full year 2021 revenue to be in the range of $90 million to $100 million, representing 40% to 56% growth over the full year 2020. Berkeley Lights Inc is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Adjust your position size based on your own risk profile. Fourth quarter 2020 revenue growth of 31% over same period of 2019EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. With analysts defining $80-$105 as the low and high price targets, we arrive at a consensus price target of $95.5 for the trailing 12-month period. Get the latest Berkeley Lights earnings report, revenues as well as upcoming BLI earnings dates, historical financial reports, news, analysis & more. Fourth quarter 2020 revenue growth of 31% over same period of 2019. Berkeley Lights Inc (BLI) stock is trading at $83.56 as of 1:26 PM on Thursday, Nov 19, a loss of -$9.45, or -10.16% from the previous closing price of $93.01. What's Happening With Berkeley Lights Inc Stock Today? About Berkeley Lights Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. About Berkeley Lights Berkeley Lights ⦠To see how Berkeley Lights, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: BLI stockâs performance was -2.18% in the latest trading, and 0% in the past year, while Bristol-Myers Squibb Company (BMY) has traded -0.44% on the day and positioned -5.08% lower than it was a year ago. Investors; Careers; Resources; Support; Get In Touch; Workflow Cell Line Development Best cell lines for complex antibody therapeutics with unrivaled clonality assurance in just days. Investors also watch the number of corporate investors in a company very closely, which is 109 institutions for Berkeley Lights, Inc. that are currently holding shares of the company. Today, Berkeley Lights is valued at around $4 billion. Varian and Paxion Capital Partners are the most recent investors. ADVERTISEMENT. Berkeley Lights Investments (1) Company Name Deal Date Deal Type Deal Size Industry Lead Partner; 000000 00000000000: 07-Mar ⦠The Berkeley Lights Platform can move you toward cell-based breakthroughs faster than you can imagine. The top two institutional holders are SC US (TTGP) Ltd with over 8.05 Million shares worth more than $614.55 Million. Investors; Careers; Resources; Support; Get In Touch; Berkeley Lights Resource Center. Further, Berkeley Lights, Inc. (BLI) has a beta value of 0, and an average true range (ATR) of 4.34. This is a new way to capture and interpret the qualitative language of biology and translate it into single-cell specific digital information, referred to as Digital Cell Biology. Berkeley Lights, Inc. (NASDAQ:BLI) Stock Could Reward Investors With a 36.57% Gain. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. But biologists need to move faster and more efficiently to meet todayâs scientific demands. The firm is expected to [â¦] Berkeley Lights is funded by 13 investors. Site by Metropolis. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the Berkeley Group website. Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights has a post-money valuation in the range of $500M to $1B as of Oct 15, 2018, according to PrivCo. There are currently 1 hold rating and 5 buy ratings for the stock. Four analysts have made estimates for Berkeley Lightsâ earnings, with the highest sales estimate coming in at $19.66 million and the lowest estimate coming in at $17.60 million. Berkeley Lights has received at least $235 million from investors including WRVI Capital, Sequoia Capital, Igor Khandros, and Nikon Corporation. We currently focus on enabling the large and rapidly growing markets of antibody therapeutics, cell therapy and synthetic biology with our platform. The platform uses optofluidics ⦠Linda Haig - January 27, 2021. Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. Berkeley Lights Fourth Quarter 2020 Earnings Conference Call, 39th Annual J.P. Morgan Virtual Healthcare Conference. The Berkeley Lights IPO looks promising, and BLI looks promising as a company. Subscription includes access to all devices. Berkeley Lights has a post-money valuation in the range of $500M to $1B as of Oct 15, 2018, according to PrivCo. Pinterest. info@berkeleylights.com Berkeley Lightsâ management is scheduled to participate in a fireside chat on Thursday, March 4 at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern Time. The stock has traded between $101.54 and $113.53 so far today. After all, ⦠Eric Hobbs, Ph.D. ⦠Berkeley Lights has raised a total of $235 in funding over 8 rounds. It aims to provide platforms that automate the manipulation and analysis of cells. Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. With the companyâs per share price at $73.22 changed hands at ⦠Berkeley Lights, Inc. is a Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. We'd expect to see both institutions and retail investors owning a portion of the company. © 2021 Berkeley Lights, Inc.. All Rights Reserved. About Berkeley Lights Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and ⦠Data Provided by Refinitiv. Berkeley Lights is registered under the ticker NASDAQ:BLI . Berkeley Lights went public in July following a wildly successful IPO that raised $205M â more than double the companyâs $100M filing. The institutional investor owned 301,032 shares of the companyâs stock after buying an additional 266,882 shares during the period. By. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and delivers the live biology researchers desire in the form of the best cell. 1.51; 2.18%; Volume: 1.3 Mil . Download.
Workplace Diversity Questionnaire,
How To Remove Dead Fish From Pond,
Roku Disney Plus Subtitles,
Cherry Shrimp Male To Female Ratio,
How To Unlock Luigi In Super Mario 35,
Blood Elf Mage Transmog,